Introduction
Leukemia Inhibitory Factor (LIF) is a lymphoid factor that plays a crucial role in maintaining embryonic stem cells in their undifferentiated state by preventing spontaneous differentiation. LIF exhibits various functions, including promoting the differentiation of cholinergic neurons, regulating stem cell pluripotency, influencing bone and fat metabolism, stimulating the growth of factor-dependent cell lines, and enhancing the production of megakaryocytes in living organisms. Notably, there is a high degree of similarity between human and mouse LIF, with 78% identical amino acid sequences.
Description
Recombinant Human LIF, produced in yeast, is a single-chain polypeptide that has undergone glycosylation. It comprises 180 amino acids and has a molecular weight of 58.5 kDa. The purification process for LIF involves specialized chromatographic techniques.
Physical Appearance
White, lyophilized (freeze-dried) powder that has been sterilized by filtration.
Formulation
The protein was lyophilized from a 0.2 μm filtered phosphate-buffered saline (PBS) solution.
Solubility
To reconstitute the lyophilized LIF, it is advised to dissolve it in sterile, 18 megaohm-centimeter (MΩ·cm) H₂O at a concentration of at least 100 μg/mL. This solution can then be further diluted into other aqueous solutions as needed.
Stability
Lyophilized LIF remains stable for up to 3 weeks at room temperature. However, for long-term storage, it is recommended to store the desiccated product at temperatures below -18°C. Once reconstituted, LIF can be stored at 4°C for 2-7 days. For longer storage periods, it should be kept at temperatures below -18°C. It is crucial to avoid repeated freeze-thaw cycles to maintain protein stability.
Purity
The purity of the protein is greater than 98.0%, as determined by the following methods: (a) Reverse-phase high-performance liquid chromatography (RP-HPLC) analysis, and (b) Sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Biological Activity
The biological activity of recombinant human LIF was evaluated based on its ability to induce the differentiation of murine M1 myeloid leukemia cells. The minimum concentration of human LIF required to elicit a detectable response in this assay is less than 0.05 ng/mL. The specific activity of the protein is greater than 1 x 10⁸ units/mg.
Synonyms
CDF, HILDA, D-FACTOR, Differentiation- stimulating factor, Melanoma-derived LPL inhibitor, MLPLI, Emfilermin, Leukemia inhibitory factor, LIF, DIA.
Amino Acid Sequence
S P L P I T P V N A T C A I R H P C H N N L M N Q I R S Q L A Q L N G S A N A L F I L Y Y T A Q G E P F P N N L D K L C G P N V T D F P P F H A N G T E K A K L V E L Y R I V V Y L G T S L G N I T R D Q K I L N P S A L S L H S K L N A T A D I L R G L L S N V L C R L C S K Y H V G H V D V T Y G P D T S G K D V F Q K K K L G C Q L L G K Y K Q I I A V L A Q A F.